Skip to main content
CVS
NYSE Trade & Services

CVS Crushes Q2 Estimates, Raises Full-Year Profit Outlook

Tom Rudovsky · Reported by Reuters
More coverage: Consumer
Sentiment info
Positive
Importance info
9
Price
$107.5
Mkt Cap
$133.232B
52W Low
$61.35
52W High
$110.68
52W Position info
75% above low
Off High info
2.9% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CVS sits 75% above its 52-week low of $61.35.

Summary

CVS Health delivered a massive Q2 beat, with adjusted EPS of $2.58 nearly 40% above the $1.85 consensus, driven by a sharp rebound in its Health Care Benefits segment. Revenue surged to $106.1 billion, well ahead of the $100.1 billion estimate, while the medical benefit ratio improved to 87.4% versus the expected 90.03%. Management raised full-year adjusted EPS guidance to $7.90-$8.10, significantly above the $7.45 Street view, and set cash flow from operations at $11.5 billion or more. The company also detailed new GLP-1 initiatives, including $29 MinuteClinic virtual visits and transparent pricing for Zepbound and Foundayo by early Q4, building on its recent weight-management program revamp. This follows a series of positive developments, including projected Medicare Advantage rate increases and expanded GLP-1 coverage, though legal overhangs from the Florida AG subpoena and FTC settlement remain. The stock, trading near its 52-week high, is likely to see strong upward pressure on these results.

Updates

  1. · SEC 8-K — GAAP diluted EPS was $2.31, up from $0.80 a year earlier; full-year GAAP EPS guidance raised to $6.84-$7.04 from $6.24-$6.44.

At the time of this announcement, CVS was trading at $107.50 on NYSE in the Trade & Services sector, with a market capitalization of approximately $133.2B. The 52-week trading range was $61.35 to $110.68. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CVS - Latest Insights

CVS
Nov 04, 2026, 1:48 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $80.13
Real-time Price: $78.50 info
Change: -$1.63 (-2%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:41 AM EST
Source: Reuters
Importance Score:
9
Price at Filing: $93.20
Real-time Price: $78.50 info
Change: -$14.70 (-16%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:34 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $91.86
Real-time Price: $78.50 info
Change: -$13.36 (-15%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $91.49
Real-time Price: $78.50 info
Change: -$12.99 (-14%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $91.84
Real-time Price: $78.50 info
Change: -$13.34 (-15%) info
Market Cap: $103.433B info